Results 191 to 200 of about 156,110 (291)

Epidemiological Assessment of Benzodiazepine Dependence via Pharmacist-Led EMR Review in Pain and Palliative Care Institution. [PDF]

Pharmacy (Basel)
Estrada-De La Rosa CE, Avalos-Salgado FA, Suárez-Rico DO, Zermeño-Ruiz M, Cortez-Álvarez CR, Escutia-Gutiérrez R.   +5 more
europepmc   +1 more source

‘Peripheral’ Benzodiazepine Receptor Ligands Stimulate Prolactin Release in the Rat [PDF]

, 1990
Aldo E. Calogerot, Themis C. Kamilaris, Eric O. Johnson, Philip W. Gold, George P. Chrousos   +4 more
openalex   +1 more source

No Effect of Low‐Dose Aspirin Versus Placebo as Add‐On Treatment in Bipolar Disorder—Results From a Randomised Controlled Trial (the A‐Bipolar RCT)

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Robust evidence associates immunoinflammatory dysfunction and bipolar disorder (BD), with immune dysregulation present in patients newly diagnosed with BD. This suggests that anti‐inflammatory agents, like low‐dose aspirin (LDA), might be repurposed in the treatment of early‐stage BD.
Caroline Fussing Bruun, Helle B. Krogh, Jeff Zarp, Julie Ravneberg Stokholm, Julie Lyng Forman, Kamilla Woznica Miskowiak, Annamaria Giraldi, Maj Vinberg, Maria Faurholt‐Jepsen, Lars Vedel Kessing   +9 more
wiley   +1 more source

Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study

Addiction, EarlyView.
Abstract Background & Aims There are few effective treatments for methamphetamine use disorder, despite increasing global demand. Here, we assessed the safety and feasibility of outpatient psilocybin‐assisted psychotherapy for methamphetamine use disorder. Design Single arm, open label pilot study.
Elizabeth Knock, Krista J. Siefried, Gill Bedi, Steven Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett   +8 more
wiley   +1 more source

A feasibility study of a co-designed intervention to manage benzodiazepine dependence and high-risk use in those receiving opioid agonist treatment. [PDF]

Pilot Feasibility Stud
Matheson C, Berry K, Kilonzo M, Galea-Singer S, Hill D, Ritchie T, Schofield J, Stewart D, Turner M, MacLennan G.   +9 more
europepmc   +1 more source

Patient Outcomes Associated With Phenobarbital Use With or Without Benzodiazepines for Alcohol Withdrawal Syndrome: A Systematic Review

, 2017
Drayton A. Hammond, Jordan M. Rowe, Adrian Wong, Tessa Wiley, Kristen C. Lee, Sandra L. Kane‐Gill   +5 more
openalex   +2 more sources

Evaluating the optimal duration of medication treatment for opioid use disorder

Addiction, EarlyView.
Abstract Background and aims Clinicians have little guidance on the ideal length of time patients should remain on medication treatment for opioid use disorder (MOUD) before being able to safely discontinue MOUD. This study estimated how the risk of all‐cause mortality changes with the duration of MOUD, controlling for patient characteristics that ...
Corey J. Hayes, Rebecca A. Raciborski, Mahip Acharya, Nahiyan Bin Noor, Edward V. Nunes, T. John Winhusen   +5 more
wiley   +1 more source

Possible Effect of Governmental Restrictions of Benzodiazepine Prescriptions on Suicide Attempts by Overdose of Prescribed Psychotropic Drugs in Japan. [PDF]

Neuropsychopharmacol Rep
Akahane A, Matsumura K, Mashiko Y, Kanai R, Kunugi H.   +4 more
europepmc   +1 more source

Mandatory Review of Prescription Drug MonitoringProgram Before Issuance of a Controlled SubstanceResults in Overall Reduction of PrescriptionsIncluding Opioids and Benzodiazepines

, 2020
Alaa Abd‐Elsayed
openalex   +1 more source

Characteristics of methamphetamine‐related deaths in the United Kingdom, 1997–2024

Addiction, EarlyView.
Abstract Background and aims People who use methamphetamine have a standardised mortality ratio 6.8 times greater than the general population, with several countries reporting concerning increases in methamphetamine‐related mortality over the past decade.
Emmert Roberts, Rebecca McKetin, Caroline Copeland   +2 more
wiley   +1 more source